News

Novartis enters into licensing agreement with Ionis

| Szilvana Spett, BaselArea/Café Europe
Novartis enters into licensing agreement with Ionis
The Basel-based pharmaceutical group Novartis is expanding its cardiovascular portfolio by entering into an exclusive option agreement with the US company Ionis and its affiliate Akcea to license two novel treatments. More…

Dubai state fund invests in Centralway Numbrs

| Szilvana Spett, GreaterZurichArea/Café Europe
Dubai state fund invests in Centralway Numbrs
The Investment Corporation of Dubai has invested in the Zurich-based Fintech company Centralway Numbrs, which produces an app that allows users to manage their bank accounts. With the investment, Centralway Numbrs intends to further strengthen its market position. More…

Enterprises in Switzerland invested over CHF 15 billion in R&D

| Fabienne Schneider, S-GE
Enterprises in Switzerland invested over CHF 15 billion in R&D
In 2015, investments in research and development activities from enterprises in Switzerland amounted to more than CHF 15.7 billion. This corresponds to an increase of 10% compared to 2012. More…

Company Founders Cherish Lucerne

| Paul Felber, AKOMAG Corporate Communications AG
Company Founders Cherish Lucerne
In 2016 1056 new companies have been established in Canton Lucerne. Compared with other locations, this is the strongest growth rate. More…

Singulex opens European headquarters in Basel

| Szilvana Spett, BaselArea/Café Europe
Singulex opens European headquarters in Basel
The American biotechnology company Singulex is opening its first office outside the USA in Basel. BaselArea.swiss has supported the company, which now plans to market its in-vitro diagnostics platform Sgx Clarity System in Europe. More…

Vatorex wins seed capital

| Szilvana Spett, GreaterZurichArea/Café Europe
Vatorex wins seed capital
Vatorex won CHF 130,000 in seed capital at Venture Kick finale. The Winterthur-based start-up is developing a novel hyperthermia treatment to fight varroa mites in bee hives. More…

Evolva expects to receive patent for stevia sweetener

| Szilvana Spett, BaselArea/Café Europe
Evolva expects to receive patent for stevia sweetener
Evolva, which manufactures ingredients for health, wellness and nutrition, has received permission from the US patent authorities for its patent application covering the production method for manufacturing the best-tasting steviol glycosides. More…

Energy-saving data storage

| Paul Felber, AKOMAG Corporate Communications AG
Energy-saving data storage
Researchers at the Paul Scherrer Institute (PSI) in Villigen, Canton Aargau, have created a new material that is very promising for future data storage devices. More…

Freezyboy solves compost problems

| Paul Felber, AKOMAG Corporate Communications AG
Freezyboy solves compost problems
Avantyard, a start-up from Root, Canton Lucerne, is now offering a fascinating new product for sale: biological waste is frozen. More…

High-precision fight against cancer

| Paul Felber, AKOMAG Corporate Communications AG
High-precision fight against cancer
Developed at the Paul Scherrer Institute PSI in Canton Aargau, the spot scanning process in proton therapy treats patients gently and efficiently. More…
  • Swiss Business Hub India
    Head of Swiss Business Hub India
    502 Dalamal House, 5th Floor, 206, Jamnalal Bajaj Marg, Nariman Point, Mumbai
    +91 22 4343 56 00
  • Swiss Business Hub India
    Head – Investment Promotion India
    502 Dalamal House, 5th Floor, 206, Jamnalal Bajaj Marg, Nariman Point, Mumbai
    +91 22 4343 56 00